Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(Rac)-WAY-161503

Copy Product Info
🥰Excellent
Catalog No. T13332Cas No. 75704-24-4

(Rac)-WAY-161503 is a selective and high-affinity agonist of the 5-HT2C receptor [Ki: 4 nM; EC50: 12 nM], exhibiting anti-obesity and antidepressant effects.

(Rac)-WAY-161503

(Rac)-WAY-161503

Copy Product Info
🥰Excellent
Purity: 99.51%
Catalog No. T13332Cas No. 75704-24-4
(Rac)-WAY-161503 is a selective and high-affinity agonist of the 5-HT2C receptor [Ki: 4 nM; EC50: 12 nM], exhibiting anti-obesity and antidepressant effects.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$86In StockIn Stock
10 mg$119In StockIn Stock
25 mg$192In StockIn Stock
50 mg$280In StockIn Stock
100 mg$415In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.51%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
(Rac)-WAY-161503 is a selective and high-affinity agonist of the 5-HT2C receptor [Ki: 4 nM; EC50: 12 nM], exhibiting anti-obesity and antidepressant effects.
Targets&IC50
5-HT2C receptor:12 nM (EC50), 5-HT2C receptor:4 nM(Ki)
In vivo
In male C57BL/6J mice, (Rac)-WAY-161503 (3-30 mg/kg; i.p.) treatment dose-dependently decreases locomotor activity, an effect that is blocked by the 5-HT2C/2B antagonist SER-082. Additionally, in the 5-HT2A KO mice, the decreased locomotor activity produced by 10 mg/kg DOI is potentiated [1].
Chemical Properties
Molecular Weight272.13
FormulaC11H11Cl2N3O
Cas No.75704-24-4
SmilesClc1cc2NC(=O)C3CNCCN3c2cc1Cl
Relative Density.1.54 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 90 mg/mL (330.72 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (12.13 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.6747 mL18.3736 mL36.7471 mL183.7357 mL
5 mM0.7349 mL3.6747 mL7.3494 mL36.7471 mL
10 mM0.3675 mL1.8374 mL3.6747 mL18.3736 mL
20 mM0.1837 mL0.9187 mL1.8374 mL9.1868 mL
50 mM0.0735 mL0.3675 mL0.7349 mL3.6747 mL
100 mM0.0367 mL0.1837 mL0.3675 mL1.8374 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy (Rac)-WAY-161503 | purchase (Rac)-WAY-161503 | (Rac)-WAY-161503 cost | order (Rac)-WAY-161503 | (Rac)-WAY-161503 chemical structure | (Rac)-WAY-161503 in vivo | (Rac)-WAY-161503 formula | (Rac)-WAY-161503 molecular weight